Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed question first answered answering member label
tabling member	label

Search

79074

	registered interest
	date	21/07/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Congenital Myasthenic Syndrome
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what discussions he has had with the British Medical Association on the prescribing of salbutamol to treat congenital myasthenia.
	tabling member constituency	Strangford
	tabling member printed	Jim Shannon
	uin	206798
	answer	answer is ministerial correction date of answer 04/09/2014 answer text <p>Ministers have had no such discussions.</p><p>Salbutamol is not licenced for the treatment of congenital myasthenia. Doctors can prescribe a medicine outside the terms of its licence if this best meets the clinical need of an individual patient and on condition that they retain full clinical responsibility for that patient.</p><p> </p> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 04/09/2014 13:56:17 answering member 4020 label Biography information for George Freeman
	tabling member	4131 label Biography information for Jim Shannon

90152

	registered interest
	date	01/09/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Prescription Drugs
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what recent discussions he has had with his counterpart in the Northern Ireland Executive on ensuring availability of drugs to treat cancer and MS in all parts of the UK.
	tabling member constituency	Strangford
	tabling member printed	Jim Shannon
	uin	207704
	answer	answer is ministerial correction date of answer 08/09/2014 answer text <p>We have had no such discussions.</p><p> </p><p>As the hon. Member will be aware, health is devolved in Northern Ireland and is the responsibility of the Department of Health, Social Services and Public Safety in the Northern Ireland Executive.</p><p> </p> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 08/09/2014 16:22:16 answering member 4020 label Biography information for George Freeman
	tabling member	4131 label Biography information for Jim Shannon

90154

	registered interest
	date	01/09/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Sildenafil: Prescriptions
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, how many people in each age group were prescribed Viagra through the NHS in each of the last five years.
	tabling member constituency	Strangford
	tabling member printed	Jim Shannon
	uin	207708
	answer	answer is ministerial correction date of answer 08/09/2014 answer text <p>Information is not collected centrally on the number of people prescribed medicines or the medical condition being treated. However, information is available on the number of prescription items dispensed in the community in England.</p><p>Viagra is a brand name for the chemical Sildenafil. The table below shows the number of prescription items dispensed for Sildenafil, broken down by brand names, for the last five years.</p><p>The number of prescription items for Sildenafil (British National Formulary (BNF) Section 7.4.5 Drugs for erectile dysfunction), by brand name, written in the United Kingdom and dispensed in the community, in England (000s) <sup>1</sup></p><p> </p><table><tbody><tr><td><p>Year</p></td><td><p>Napatra</p></td><td><p>Sildenafil</p></td><td><p>Viagra</p></td><td><p>Total</p></td></tr><tr><td><p>2009</p></td><td><p>-</p></td><td><p>1.1</p></td><td><p>1,231.8</p></td><td><p>1,232.9</p></td></tr><tr><td><p>2010</p></td><td><p>-</p></td><td><p>1.3</p></td><td><p>1,274.8</p></td><td><p>1,276.1</p></td></tr><tr><td><p>2011</p></td><td><p>-</p></td><td><p>1.1</p></td><td><p>1,278.3</p></td><td><p>1,279.4</p></td></tr><tr><td><p>2012</p></td><td><p>-</p></td><td><p>1.4</p></td><td><p>1,286.2</p></td><td><p>1,287.6</p></td></tr><tr><td><p>2013 <sup>2</sup></p></td><td><p>0.6</p></td><td><p>830.7</p></td><td><p>566.6</p></td><td><p>1,397.9</p></td></tr></tbody></table><p><em>Notes</em>:</p><p><sup>1 </sup>Figures are for BNF Section 7.4.5 Drugs for erectile dysfunction only. Sildenafil also appears in BNF Section 2.5.1 Vasodilator antihypertensive drugs.</p><p><sup>2 </sup>In June 2013 Viagra came of patent. There was a shift in prescribing practice with an increase in prescribing of Sildenefil by its generic name and a corresponding decline in the prescribing of the branded Viagra.</p><p><em>Source</em>: Prescription Cost Analysis provided by the Health and Social Care Information Centre</p><p> </p> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 08/09/2014 14:50:25 answering member 4020 label Biography information for George Freeman
	tabling member	4131 label Biography information for Jim Shannon

90159

	registered interest
	date	01/09/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Pregnancy: Folic Acid
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, how many pregnant women received folic acid through NHS prescription to prevent hydrocephalus in each of the last five years.
	tabling member constituency	Strangford
	tabling member printed	Jim Shannon
	uin	207703
	answer	answer is ministerial correction date of answer 08/09/2014 answer text <p> </p><p>Information is not collected centrally on the number of people prescribed medicines or the medical condition being treated. However, information is available on the number of prescription items dispensed in the community in England. The following table provides information on folic acid for the latest available 5 year period:</p><p> </p><p> </p><p> </p><table><tbody><tr><td colspan="2"><p>The number of prescription items for folic acid, written in the United<br> Kingdom and dispensed in the community, in England</p></td></tr><tr><td><p>Year</p></td><td><p>Items (000s)</p></td></tr><tr><td><p>2009</p></td><td><p>3,459.8</p></td></tr><tr><td><p>2010</p></td><td><p>3,953.8</p></td></tr><tr><td><p>2011</p></td><td><p>4,426.0</p></td></tr><tr><td><p>2012</p></td><td><p>4,930.1</p></td></tr><tr><td><p>2013</p></td><td><p>5,444.2</p></td></tr></tbody></table><p> </p><p><em> </em></p><p> </p><p><em>Source:</em> Prescription Cost Analysis provided by the Health and Social Care Information Centre</p><p> </p> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 08/09/2014 14:31:16 answering member 4020 label Biography information for George Freeman
	tabling member	4131 label Biography information for Jim Shannon

91290

	registered interest
	date	09/09/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Stem Cells
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what plans the NHS has to introduce stem-cell treatment as a substitute for hip and knee replacements.
	tabling member constituency	Strangford
	tabling member printed	Jim Shannon
	uin	208766
	answer	answer is ministerial correction date of answer 13/10/2014 answer text <p>The National Health Service supports the development of all stem cell research in the hope of adopting effective therapies for the future but will only recommend routine use when it is judged to be effective and safe.</p><p> </p><p>A number of NHS and academic units in the United Kingdom are actively involved in research and evaluation of techniques using stem cells to promote cartilage regeneration in hips and knees. Whilst the research is potentially promising, evaluation of the clinical effectiveness, including a National Institute for Health and Care Excellence review into cellular techniques to regenerate cartilage, has not supported the routine use of these type of techniques unless as part of a controlled ongoing scientific trial.</p><p> </p> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 13/10/2014 15:41:46 answering member 4020 label Biography information for George Freeman
	tabling member	4131 label Biography information for Jim Shannon

91291

	registered interest
	date	09/09/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Gout
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what estimate he has made of the cost to the NHS of drug treatments for gout in each of the last five years.
	tabling member constituency	Strangford
	tabling member printed	Jim Shannon
	uin	208764
	answer	answer is ministerial correction date of answer 13/10/2014 answer text <p>Data on the costs of a particular condition, for which a medicine is prescribed, is not collected. Information on the cost to the National Health Service of the medicines listed under British National Formulary (BNF) section 10.1.4 - Gout and cytotoxic-induced hyperuricaemia is shown in the table. These medicines include allopurinol, benzbromarone, colchicine, febuxostat, probenecid and sulfinpyrazone.<strong> </strong>Rasburicase is not included as it is used to treat cytotoxic-induced hyperuricaemia.</p><p> </p><p> </p><p> </p><p>The BNF also states that acute attacks of gout are usually treated with non-steroidal anti inflammatory drugs (NSAIDs) but, as it is not possible to identify what proportion of the NSAIDs dispensed were used specifically for the treatment of gout, these costs are not included.</p><p> </p><p> </p><p> </p><table><tbody><tr><td><p>Year</p></td><td><p>Net ingredient cost of drugs used in gout in primary and secondary care<sup>1</sup></p><p>£000s</p></td></tr><tr><td><p>2009</p></td><td><p>9,850.0</p></td></tr><tr><td><p>2010</p></td><td><p>12,449.7</p></td></tr><tr><td><p>2011</p></td><td><p>11,703.0</p></td></tr><tr><td><p>2012</p></td><td><p>14,445.3</p></td></tr><tr><td><p>2013</p></td><td><p>15,900.9</p></td></tr></tbody></table><p> </p><p><em>Source:</em> Prescription Cost Analysis and IMS HEALTH: Hospital Pharmacy Audit supplied by the Health and Social Care Information Centre</p><p> </p><p><strong> </strong></p><p> </p><p><sup>1 </sup>The net ingredient cost does not include costs associated with prescribing, dispensing and related activities, and excludes discounts that may be applied.</p><p> </p><p><strong> </strong></p><p> </p> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 13/10/2014 15:35:32 answering member 4020 label Biography information for George Freeman
	tabling member	4131 label Biography information for Jim Shannon

92971

	registered interest
	date	13/10/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Cancer: Drugs
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what recent steps he has taken to ensure the continuing availability of cancer drugs.
	tabling member constituency	Strangford
	tabling member printed	Jim Shannon
	uin	210259
	answer	answer is ministerial correction date of answer 20/10/2014 answer text <p>Patients have the right to cancer drugs and treatments that have been recommended by the National Institute for Health and Care Excellence technology appraisal guidance for use in the National Health Service, where their doctor believes they are clinically appropriate.</p><p> </p><p> </p><p> </p><p>We announced in August that the Cancer Drugs Fund would be increased to £280 million in both 2014-15 and 2015-16. Since October 2010, over 55,000 cancer patients in England have benefitted from the Fund.</p><p> </p><p> </p><p> </p> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 20/10/2014 16:47:06 answering member 4020 label Biography information for George Freeman
	tabling member	4131 label Biography information for Jim Shannon

92973

	registered interest
	date	13/10/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Paralysis: Medical Equipment
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what recent discussions he has had about the use of titanium implants to enable people who are paralysed by injury to regain their mobility.
	tabling member constituency	Strangford
	tabling member printed	Jim Shannon
	uin	210251
	answer	answer is ministerial correction date of answer 20/10/2014 answer text <p>The Medicines and Healthcare products Regulatory Agency has not been involved in any recent discussions about the use of titanium implants to enable people who are paralysed by injury to regain their mobility.</p><p> </p> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 20/10/2014 16:54:08 answering member 4020 label Biography information for George Freeman
	tabling member	4131 label Biography information for Jim Shannon